Author:
Zhou Wei,Liu Yisi,Tian Dongdong,Wang Cheng,Wang Sa,Cheng Jing,Hu Ming,Fang Minghao,Gao Yue
Funder
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference12 articles.
1. National Health Commission of the People’s Republic of China. National Health Commission’s briefing on the pneumonia epidemic situation released on 10 Feb 2020 (in Chinese). http://www.nhc.gov.cn/xcs/yqtb/202002/167a0e01b2d24274b03b2ca961107929.shtml (2020).
2. Wang, W., Tang, J. & Wei, F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J. Med. Virol. https://doi.org/10.1002/jmv.25689 (2020).
3. National Health Commission of the People’s Republic of China. The 5th trial version of Diagnosis and Treatment Scheme for Pneumonitis with 2019-nCoV Infection (In Chinese). http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a.shtml (2020).
4. Russell, C. D., Millar, J. E. & Baillie, J. K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. https://doi.org/10.1016/s0140-6736(20)30317-2 (2020).
5. Jiang, S. et al. Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: a meta-analysis. Medicine 98, e16239 (2019).
Cited by
183 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献